HGH-V gene expression and promoter activity under glucose and 5-azacytidine (5azaC) effects

Gene

Volumn 452, Issue 1, 2010, Pages 7-15

  de Jesús Romero Prado, Marina Maria ^a,c   Barrera Saldaña, Hugo A ^b   Castrillo Diez, Jose Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Genome demethylation; Glucose effects; PACs

Indexed keywords

AZACITIDINE; GLUCOSE; GROWTH HORMONE; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLACENTAL GROWTH HORMONE; PROTEIN H4TF 1; PROTEIN HES 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE EXPRESSION; GENETIC REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING;

AZACITIDINE; BASE SEQUENCE; CELL LINE; CELL LINE, TUMOR; CHROMOSOMES, ARTIFICIAL, P1 BACTERIOPHAGE; DNA METHYLATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETIC LOCI; GENOME, HUMAN; GLUCOSE; GROWTH HORMONE; HUMANS; MOLECULAR SEQUENCE DATA; PLACENTA; PLACENTAL HORMONES; PLACENTAL LACTOGEN; PREGNANCY; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 74449084528     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2009.11.012     Document Type: Article

References (52)

1. Barrera-Saldaña H.A. Growth hormone and placental lactogen: biology, medicine and biotechnology. Gene 1998, 211:11-18.
2. Barsh G.S., Seeburg P.H., Gelinas R.E. The human growth hormone gene family: structure and evolution of the chromosomal locus. Nucl. Acid. Res. 1983, 11:3939-3958.
3. Bennani-Baiti I.M., Asa S.L., Song D., Iratni R., Liebhaber S.A., Cooke N.E. Dnase I-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:10655-10660.
4. Blanchon L., Bocco J.L., Gallot D., et al. Co-localization of KLF6 and KLF4 with pregnancy-specific glycoproteins during human placenta development. Mech. Dev. 2001, 105:185-189.
5. Bousiff O., et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7297-7301.
6. Cheng K.W., Chow B.K., Leung P.C. Functional mapping of a placenta-specific upstream promoter for human gonadotropin-releasing hormone receptor gene. Endocrinology 2001, 142:1506-1516.
7. Chen E.Y., Liao Y.C., Smith D.H., Barrera-Saldaña H.A., Gelinas R.E., Seeburg P.H. The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 1989, 4:479-497.
8. Canizales-Espinoza M., Martínez-Rodríguez H.G., Vila V., et al. Differential strength of transfected human growth hormone and placental lactogen gene promoters. J. Endocrine Genetics 2005, 4:25-35.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-CHCL3 extraction. Anal. Biochem. 1987, 162:156-164.
10. Chow C-M., Athanassiadou A., Raguz, et al. LCR-mediated, long-term tissue-specific gene expression within replicating episomal plasmid and cosmid vectors. Gen. Ther. 2002, 9:327-336.
11. Dailey L., Hanly S.M., Roeder R.G., Heintz H. Distinct transcription factors bind specifically to two regions of the human histone promoter. Proc. Natl. Acad. Sci. USA 1986, 83:7241-7245.
12. Delhase M., Castrillo J.L., de la Hoya M., Rajas F., Hooghe-Peters E.L. AP-1 and Oct-1 transcription factors down-regulate the expression of the human PIT1/GHF1 gene. J. Biol. Chem. 1996, 271:32349-32358.
13. Ent F.M.I., et al. Concerted control of multiple histone promoter factors during cell density inhibition of proliferation in osteosarcoma cells: reciprocal regulation of cell cycle-controlled and bone-related genes. Cancer Res. 1993, 53:2399-2409.
14. Goel A., Mathupala S.P., Pedersen P.L. Glucose metabolism in cáncer. Evidence that demethylation events play a role in activating type II hexokinase gene expression. J. Biol. Chem. 2003, 278:15333-15340.
15. Ishibasi M., Sasai Y., Nakanishi S., Kageyama R. Molecular characterization of HES-2, a mammalian helix-loop-helix factor structurally related to Drosophila hairy and Enhancer of split. Eur. J. Biochem. 1993, 215:645-652.
16. Iso T., Kedes L., Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J. Cell. Physiol. 2003, 194:237-255.
17. Jacquemin P., Oury C., Peers B., Morin A., Belayew A., Martial J.A. Characterization of a single strong tissue-specific enhancer downstream from the three human genesencoding placental lactogen. Mol. Cell. Biol. 1994, 14:93-103.
18. Jimenez-Mateo O., Rodriguez-Torres A., Avila S., Castrillo J.L. The transcription factor PLA-1/SKN-1A is expressed in human placenta and regulates the placental lactogen-3 gene expression. Placenta 2006, 27:357-366.
19. Jones B.K., Monks B.R., Liebhaber S.A., Cooke N.E. The human growth hormone gene is regulated by a multicomponent locus control region. Mol. Cell. Biol. 1995, 15:7010-7021.
20. Kamei Y., Tsutsumi O., Yamakawa A., Oka Y., Taketani Y., Imaki J. Maternal epidermal growth factor deficiency causes fetal hypoglycemia and intrauterine growth retardation in mice: possible involvement of placental glucosa transporter GLUT3 expression. Endocrinology 1999, 140:4236-4243.
21. Katoh M., Katoh M. Identification and characterization of human HES2, HES3 and HES5 genes in silico. Int. J. Oncol. 2004, 25:529-534.
22. Knöfler M., Saleh L., Bauer S., Galos B., Rotheneder P.H., Helmer H. Transcription regulation of the human chorionic gonadotropin b gene during villous trophoblast differentiation. Endocrinology 2004, 145:1685-1694.
23. Lacroix M-C., et al. Stimulation of human trophoblast invasion by placental growth hormone. Endocrinology 2005, 146:2434-2444.
24. Lyko F., Paro R. Chromosomal elements conferring epigenetic inheritance. BioEssays 1999, 21:824-832.
25. Lytras A., Bock M.E., Dodd J.G., Cattinni P.A. Detection of placental growth hormone variant and chorionic somatomammotropin ribonucleic acid expression in human trophoblastic neoplasms by reverse transcriptase-polymerase chain reaction. Endocrinology 1994, 134:2461-2467.
26. Marchuk D, Drumm M, Saulino A, Collins FS Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucl Acid Res. 1990, 19:1154.
27. McIntyre, H.D., Serek, R., Crane, D.I., et al., 2000. Placental growth hormone (GH), GH-Binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J. Clin. Endocrin. Metab. 85, 1143-1150.
28. Nakayama H., Liu Y., Stifani S., Cross J.C. Developmental restriction of Mash-2 expression in trophoblast correlates with potential activation of the Notch-2 pathway. Dev. Genet. 1997, 21:21-30.
29. Nickel B.E., Kardami E., Cattini P.A. Differential expression of human placental growth hormone variant and chorionic somatomammotropin in culture. Biochem. J. 1990, 267:653-658.
30. Nickel B.E., Cattini P.A. Tissue-specific expression and thyroid hormone regulation of the endogenous placental growth hormone variant and chorionic somatomammotropin genes in a human choriocarcinoma cell line. Endocrinology 1991, 128:2353-2359.
31. Nickel B.E., Bock M.E., Natchigal M.W., Cattini P.A. Differential expression of human placental growth hormone variant and chorionic somatomammotropin genes in choriocarcinoma cells treated with methotrexate. Mol. Cell Endocrinol. 1993, 91:159-166.
32. Pavan L., et al. Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology 2004, 145:4583-4591.
33. Patel N., et al. Glucose inhibits human placental GH secretion, in vivo. J. Clin. Endocrin. Metab. 1995, 80:1743-1746.
34. Pieper R.O., Lester K.A., Fanton C.P. Confluence-induced alterations in CpG island methylation in cultured normal human fibroblasts. Nucleic Acids Res. 1999, 27:3229-3235.
35. Reeves R., Gorman C.M., Howard B. Minichromosome assembly of non-integrated plasmid DNA into mammalian cells. Nucl. Acid Res. 1985, 13:3599-3615.
36. Ringer G.E., Strauss J.F. In vitro systems for the study of human placental endocrine function. Endocrine Rev. 1990, 11:105-123.
37. Romero-Prado M., Castrillo-Diez J.L. Regulación epigenética del gen humano de la Hormona de Crecimiento hipofisiaria (HGH-N). Rev. Invest. Clin. 2004, 56:836-837.
38. Rosen E.D., Spiegelman B.M. PPARg: a nuclear regulator of metabolism, differentiation and cell growth. J. Biol. Chem. 2001, 276:37731-37734.
39. Rudek M.A., et al. Pharmacokinetics of 5-azacitidine administered with phenylbutyrate in patients with refractory solid tumors or haematological malignancies. J. Clin. Oncol. 2006, 23:3906-3911.
40. Sato M., Miyado K., Kimura K. Cloning and characterization of -5'-upstream sequence of the M32 gene for a mouse homologue of Drosophila heterochromatin protein 1 (HP1). DNA Seq. 2001, 12:97-106.
41. Sccipo M.L., Frankenne F., Hooge-Peters E.L., Igout A., Velkeniers B., Hennen G. Syncytiotrophoblastic localization of the human growth hormone variant mRNA in the placenta. Mol. Cell Endocrinol. 1993, 97:R7-R13.
42. Schaiff W.T., Carlson M.G., Smith S.D., Levy R., Nelson D.M., Sadovsky Y. Peroxisome proliferator-activated receptor-g modulates differentiation of human trophoblast in a ligand-specific manner. J. Clin. Endocrinol. Metab. 2000, 85:3874-3881.
43. Schaiff W.T., Barak Y., Sadovsky Y. The pleiotrophic function of PPARg in the placenta. Mol. Cell Endocrinol. 2006, 249:10-15.
44. Schaiff W.T., Knapp F.F., Barak Y., Nelson M., Sadovsky Y. Ligand-activated peroxisome proliferator activated receptor g alters placental morphology and placental fatty acid uptake in mice. Endocrinology 2007, 148:3625-3634.
45. Schanke J.T., Durning M., Johnson K.J., Bennett L.K., Golos T.G. SP1/SP3-binding sites and adjacent elements contribute to basal and cyclic adenosine 3',5'-monophosphate-stimulated transcriptional activation of the rhesus growth hormone-variant gene in trophoblasts. Mol. Endocrinol. 1998, 12:405-417.
46. Sheikh S., Satoskar P., Bahrtiya D. Expression of insuli-like growth factor-I and placental growth hormone mRNA in placentae: a comparison between normal and intrauterine growth retardation pregnancies. Mol. Hum. Reprod. 2001, 7:287-292.
47. Shewchuk B.M., Cooke N.E., Liebhaber S.A. The human growth hormone locus control region mediates long-distance transcriptional activation independent of nuclear matrix attachment regions. Nucleic Acids Res. 2001, 29:3356-3361.
48. Su, Y., Liebhaber, S.A., Cooke, N.E., 2000. The human growth hormona gene cluster Locus Control Region supports position-independent pituitary- and placenta-specific expresión in the transgenic mouse. J. Biol. Chem. 275, 7902-7909.
49. Tarrade A., et al. PPARg/RXRa heterodimers control human trophoblast invasion. J. Clin. Endocrinol. & Metab. 2001, 86:5017-5024.
50. Walker, W.H., Fitzpatrick, S.L., Saunders, G.F., 1990. Sequences responsible for human placental lactogen enhancer activity and binding of placental specific nuclear proteins. J. Biol. Chem. 265, 12940-12948.
51. Walker W.H., Fitzpatrick S.L., Saunders G.F. The human placental lactogen genes: structure, function, evolution and transcriptional regulation. Endocr. Rev. 1991, 12:316-328.
52. Zeck W., Widderg C., Maylin E., et al. Regulation of Placental growth hormone secretion in human trophoblast model-the effects of hormones and adipokines. Pediatric Res 2008, 63:353-357.